AHI 0.00% 9.2¢ advanced health intelligence ltd

Ann: Appendix 4D and Half Year Financial Report, page-2

  1. 1,073 Posts.
    lightbulb Created with Sketch. 873
    A lot to swallow so haven't gone extremely deep yet, but overall, I don't think there's a lot of news for those that have been following closely.

    Loss after adding back non-cash transactions (share issue costs and impairment) looks great compared to 2019, however, this is mostly due to increased revenue, which is mostly due to the R&D refund and so doesn't give a huge indicator of revenue growth just yet, but we already knew this. Lots of new agreements but none had gone live by half year-end and so very little impact on revenue in the half-year accounts. March 21 and June 21 quarters should start to show some of the revenue from those that have since gone live.

    Cash position is strong after the mid-Dec quarter capital raise. Based on the half-year accounts total cash burn, we have enough cash to cover two years worth of operations.

    What most pleases me with the half-year accounts is all of the indicators within the report and after the reporting period which confirm that we're tracking really well for the NASDAQ listing. The board has made considerable steps forward in strengthening our team and our capabilities in advance of the listing.

    2021 CY is going to be a company making year for MYQ and I'm extremely excited to be on board for it.

    IMO.
    Last edited by SERA2g: 26/02/21
 
watchlist Created with Sketch. Add AHI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.